Roche Diabetes Care at ATTD 2019

February 20 - 23, 2019 in Berlin, Germany

Order Publications and Solution Brochures

Exhibit Info

Exhibit Info

Visit us in Hall B at booth number 7 and see how we are connecting the dots in diabetes management.

Conference Location:

Messe Berlin – CityCube Berlin

Messedamm 26

14055 Berlin, Germany

Exhibition:

CityCube Berlin, Level 2, Hall B


Booth number:

7

Opening hours:

Wednesday, February 20: 18:30 – 20:00

Thursday, February 21, 9:30 – 15:30

Friday, February 22: 9:30 – 15:30

Saturday, February 23: 9:30 – 12:00

Location map:

Roche Diabetes Care Symposium

Integrated Personalised Diabetes Management: Connecting the Dots for True Relief

Friday, February 22
Time: 10:30 – 12:00

CityCube Berlin, Level 1, Hall A7

Chairs: Antonio Ceriello (Italy), Rolf Hinzmann (Roche Diabetes Care, Germany)

Speaker

Big Data – really the future of diabetes management?

Laura Furmanski

The Boston Consulting Group

USA

Drugs, data & technology: How to overcome clinical inertia

Oliver Schnell

Ludwig-Maximilians-University and Sciarc GmbH

Germany

Insertable CGM technology with a 6 month sensor wear time: Latest clinical insights

Concetta Irace

University of Catanzaro Magna

Italy

Taking CSII to the next level: New micropump solutions and future developments

Nick Oliver

Imperial College London

United Kingdom

Abstracts & Posters

Assessment of potential errors in manual calibration of a continuous glucose monitoring system

Assessment of potential errors in manual calibration of a continuous glucose monitoring system

  • EP05 Glucose Sensors - E-Posters Exhibition area

  • Author: S. Pleus et al.

Responder analysis approach for Accu-Chek® view data: Temporal dynamics, HCP interaction – how to understand induced feedback loops

Responder analysis approach for Accu-Chek® view data: Temporal dynamics, HCP interaction – how to understand induced feedback loops

  • EP12 New Technologies for Treating Obesity and Pre-venting Related Diabetes - E-Posters Exhibition area

  • Author: J. Moecks et al.

Accu-Chek® view: Motivation, interaction and reaction under the microscope: What drives the weight-reduction success?

Accu-Chek® view: Motivation, interaction and reaction under the microscope: What drives the weight-reduction success?

  • EP12 New Technologies for Treating Obesity and Pre-venting Related Diabetes - E-Posters Exhibition area

  • Author: J. Moecks et al.

Get all Publications and Solutions Brochures via E-Mail

Order Now

Publications:

Use of an Insulin Bolus Advisor Improves Glycemic Control in Multiple Daily Insulin Injection (MDI) Therapy Patients With Suboptimal Glycemic Control: First results from the ABACUS trial
(Ziegler et al. Diabetes Care. 2013 Nov;36(11):3613-9.)
Use of an Automated Bolus Calculator in MDI-Treated Type 1 Diabetes - The BolusCal Study, a randomized controlled pilot study
(Schmidt et al. Diabetes Care. 2012 May;35(5):984-90.)
Integrated Personalized Diabetes Management (PDM): Design of the ProValue Stud-ies: Prospective, Cluster-Randomized, Controlled, Intervention Trials for Evaluation of the Effectiveness and Benefit of PDM in Patients With Insulin-Treated Type 2 Diabe-tes.
(Kulzer et al. J Diabetes Sci Technol. 2016 May 3;10(3):772-81.)
Integrated personalized diabetes management improves glycemic control in patients with insulin-treated type 2 diabetes: Results of the PDM-ProValue study program
(Kulzer et al. Diab Res Clin Pract. 2018 Oct;144:200-212)
PDM-ProValue meets cardiovascular outcome trials in diabetes
(Fritzen et al. Cardiovasc Diabetol. 2019 Jan 28;18(1):10)
A New Optimized Percutaneous Access System for CIPII
(Garcia-Verdugo et al. J Diabetes Sci Technol. 2017 Jul;11(4):814-821.)
Continuous subcutaneous insulin infusion: Special needs for children
(Adolfsson et al. Pediatr Diabetes. 2017 Jun;18(4):255-261)
Occlusion detection time in insulin pumps at two different basal rates
(Freckmann et al. J Diabetes Sci Technol 2018 ;12(3):608–613)
Establishing methods to determine clinically relevant bolus and basal rate delivery accuracy of insulin pumps
(Kamecke et al. J Diabetes Sci Technol 2018; ePub)
Patch Pumps: Are They All the Same?
(Heinemann et al. J Diabetes Sci Technol. 2019 Jan;13(1):34-40.)
Open Source Closed-Loop Insulin Delivery Systems: A Clash of Cultures or Merging of Diverse Approaches?
(Barnard et al. J Diabetes Sci Technol. 2018 Nov;12(6):1223-1226)
Insulin pump therapy, multiple daily injections, and cardiovascular mortality in 18 168 people with type 1 diabetes: observational study
(Steineck et al. BMJ 2015; 350: h3234.)
Boluses in insulin therapy
(Ziegler et al. J Diabetes Sci Technol 2017; 11(1):165-71.)
System Accuracy Evaluation of 43 Blood Glucose Monitoring Systems for Self-Monitoring of Blood Glucose According to DIN EN ISO 15197
(Freckmann et al. J Diabetes Sci Technol. 2012 Sep 1;6(5):1060-75.)
Accuracy and Longevity of an Implantable Continuous Glucose Sensor in the PRECISE Study: A 180-Day, Prospective, Multicenter, Pivotal Trial
(Kropff et al. Diabetes Care. 2017 Jan;40(1):63-68.)
A Prospective Multicenter Evaluation of the Accuracy of a Novel Implanted Continuous Glucose Sensor: PRECISE II
(Christiansen et al. Diabetes Technol Ther. 2018 Jan 30 (Epub))
What Do We Need beyond Hemoglobin A1c to Get the Complete Picture of glycemia in people with diabetes?
(Hinzmann et al. Int J Med Sci. 2012;9(8):665-81)
Use of Diabetes Data Management Software Reports by Health Care Providers, Patients With Diabetes, and Caregivers Improves Accuracy and Efficiency of Data Analysis and Interpretation Compared With Traditional Logbook Data: First Results of the Accu-Chek Connect Reports Utility and Efficiency Study (ACCRUES)
(Hinnen et al. J Diabetes Sci Technol. 2015 Mar;9(2):293-301.)
Evaluation of a new digital automated glycemic pattern detection tool
(Comellas et al. Diabetes Technol Ther. 2017 Nov 1; 19(11): 633–40.)
Use of a Novel, Remotely Connected Diabetes Management System Is Associated with Increased Treatment Satisfaction, Reduced Diabetes Distress, and Improved Glycemic Control in Individuals with Insulin-Treated Diabetes: First Results from the Personal Diabe-tes Management Study
(Mora et al. Diabetes Technol Ther. 2017 Dec 1; 19(12): 715–22.)
Modeling of Diabetes and Its Clinical Impact
(Fritzen et al. J Diabetes Sci Technol. 2018 Sep;12(5):976-984.)
Predicting the early risk of chronic kidney disease in patients with diabetes using real-world data
(Freckmann et al. J Diabetes Sci Technol 2018 ;12(3):608–613)

Brochures - Our Solutions:

Accu-Chek® Solo

  • Tube-free and small micropump
  • Quick bolus buttons on pump
  • Possibility to detach micropump or to change infusion sites without wasting insulin or the pump itself
  • Diabetes manager with open bolus advice to combine therapy with continuous glucose monitoring solutions

Eversense® XL

  • 180-days wearing time
  • Removable smart transmitter with on-body vibe alerts
  • Predictive alerts before reaching low or high glucose level
  • Data display on Smartphone
  • Simple, 5-minute in-office insertion

mySugr

  • Diabetes diary
  • Automatic data integration of leading bg meters
  • Insulin bolus calculator
  • Easy-to-read reports
  • Personal diabetes coach

Accu-Chek® Smart Pix 3.0

  • All data seamlessly available in one system
  • Easy-to-read reports for more effective therapy decisions
  • Rapidly advancing technologies to help clinicians provide data-driven care
  • A solution that is easy to install, set up, and maintain

Accu-Chek® Guide

  • Clever Strip Vial: Spill-resistant, easier to remove just one strip – with no fumbling
  • Easier Monitoring: Strip port light, wide easy edge application area and meter strip ejection
  • Your Information – All in One Place: Wirelessly transmits results to your mySugr app

Accu-Chek® View

  • Digital diary collecting data on blood glucose, exercise, blood pressure, weight, waist circumference, and medication, allowing prediabetics to monitor their behavior and become aware of patterns that can be adjusted to prevent the onset of the disease
  • Data can be shared with HCP via online portal and therapy goals can be adjusted anytime

Accu-Chek® Insight

  • Designed for easy and discreet insulin pump therapy
  • Full control of the pump via the smart diabetes manager with colored touch screen

Accu-Chek® Instant

  • Simple preparation: No set-up!
  • Instant clarity: Intuitive target range indicator
  • Effortless synchronization: No more manual diaries!

Pendiq 2.0

  • Smart insulin pen with digital and automatic insulin injection diary
  • Alarm at low-battery level, when pen needle is blocked or amount of residual insulin is too low
  • More security, precision, and quality of life

Accu-Fine® pen needles by Accu-Chek®

  • For all common insulin pens (e.g. Pendiq 2.0)
  • Gentle injection and practical handling